Skip to main content

Factor XIII Deficiency

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
NCT00885742 | PHASE 3 | INTERVENTIONAL

Congenital deficiency of factor XIII (FXIII) is an extremely rare inherited disorder associated with potentially life-threatening bleeding. Factor XIII Concentrate is given to patients whose blood is lacking factor XIII. Factor XIII Concentrate works by assisting blood in the usual clotting process, thereby preventing bleeding. In this study, patients will be treated with FXIII Concentrate (Human) and followed closely to determine that they receive the dose that will best minimize the chance of bruising and bleeding.

Trial Information
23 Sites
41 Participants
Recruiting
18 Years to 50 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Study Site
Dothan,Alabama,United States,36305
Study Site
Oakland,California,United States,94610
Study Site
Orange,California,United States,92868
Study Site
San Francisco,California,United States,94115
Study Site
Stockton,California,United States,95204
Study Site
Hartford,Connecticut,United States,06106
Study Site
Fort Meyers,Florida,United States,33908
Study
Miami,Florida,United States,33136
Study Site
Boise,Idaho,United States,83712
Study Site
South Bend,Indiana,United States,46601
Study Site
Boston,Massachusetts,United States,02115
Study Site
St. Paul,Minnesota,United States,55102
Study Site
Kansas City,Missouri,United States,64108
Study Site
Las Vegas,Nevada,United States,89015
Study Site
Lebanon,New Hampshire,United States,03756
Study Site
Newark,New Jersey,United States,07102
Study Site
Albany,New York,United States,12208
Study Site
New York,New York,United States,10021
Study Site
Chapel Hill,North Carolina,United States,27599
Study Site
Hershey,Pennsylvania,United States,17033
Study Site
Dallas,Texas,United States,75390
Study Site
Milwaukee,Wisconsin,United States,53233
Study Site
Santa Cruz de Tenerife,Spain,38009

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov